Are partners of people with HPV-related oral cancers at risk too?
Spouses and long-term partners of patients with human papillomavirus (HPV)-related oral cancers appear to have no increased risk of oral HPV infections, according to a
Spouses and long-term partners of patients with human papillomavirus (HPV)-related oral cancers appear to have no increased risk of oral HPV infections, according to a
LED Medical Diagnostics, the parent company of LED Dental, saw its 2013 first-quarter (end-March 31) revenues decline significantly year-over-year due to a shift in its
Two nutraceuticals — green tea extracts and resveratrol — have shown promise in treating various cancers, including oral squamous cell carcinoma (OSCC). But the limited
Researchers have completed a phase II clinical trial that may help identify patients with human papillomavirus (HPV)-positive oropharyngeal cancer who do not require the full
Patients with metastatic or recurrent forms of head and neck cancer respond better to systemic treatments if their tumors arise in association with the human
Just one alcoholic drink a day increases the chances of developing cancer, according to a presentation this week at an Irish Cancer Society conference. Drinking
Gastric reflux increases the risk for laryngopharyngeal squamous cell carcinoma (LPSCC), but antacids may provide protection, according to a new study in Cancer Epidemiology, Biomarkers
Routine esophageal screening can increase the early detection of second primary esophageal squamous cell carcinoma and is particularly recommended for patients with head and neck
More effective detection and diagnosis of oral cancer could result from an advance in noninvasive imaging of epithelial tissue, according to a study in Journal
Smokers do not receive oral cancer exams at a rate consistent with their risk of developing oral cancer, according to a new study in the
HuangshanDental.com is pleased to present the next installment of Leaders in Dentistry, a series of interviews with researchers, practitioners, and opinion leaders who are influencing
CDx Diagnostics has released data that support the company’s WATS3D (wide-area transepithelial sample biopsy with 3D analysis) as an additional surveillance tool to increase detection